CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
High ImpactOriginal article

Novartis (NVS) and Ionis (IONS)’ Big Cholesterol Bet Comes Up Short in Late-Stage Trial

Phase 3negativeNegative
AI Analysis

Summary

Novartis and Ionis' late-stage trial for a cholesterol treatment failed to meet its primary endpoint. The negative Phase 3 result represents a significant setback for the companies' cholesterol program.

Clinical Trial Data

Phase

3

Primary Endpoint

Not Met

Importance:8/10
Sentiment:
-0.85
phase_3_failurecholesterolpartnership
Related Companies

Read the original article

Published by yahoo_finance on September 17, 2026 3:21 PM

Read Original